Migraine with Brainstem Aura
ICD-10 G43.1 · ICD-11 8A80.1Y

Treatment of Migraine with Brainstem Aura When Oral Analgesics and NSAIDs Have Not Reduced Headache at 2 Hours

This protocol addresses acute management of migraine with brainstem aura in patients whose attack has not responded adequately to first-line oral analgesics or NSAIDs — specifically when headache reduction is not achieved within two hours of the initial dose.

Previous Line — Failure Condition

Prior therapies: Oral analgesics / NSAIDs — including ASA, ibuprofen, metamizole, diclofenac potassium, combination analgesics, and paracetamol/acetaminophen — with anti-emetics (metoclopramide or domperidone) used when nausea or vomiting was present.

Failure criterion: Insufficient reduction of headache at 2 hours after administration.

Next-Line Approach

When oral analgesics have not provided adequate headache relief, the protocol escalates to a targeted class of acute migraine therapies — 5-HT1B/1D-agonists (triptans) — with specific clinical requirements around the timing of administration relative to the aura phase.

Treatment Goal

Freedom from pain at 2 hours after administration, with defined guidance on recurrence management after initial effectiveness.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1177/2514183X1882337

View source ↗